Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Seeking Alpha / 1 hour from now 2 Views
Longeveron announces 2024 financial results and provides business update. Pivotal Phase 2b clinical trial achieves 90% enrollment.
Comments